← Leaderboards
Robert B. Nussenblatt
National Eye Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Eye Institute
Same institution · by research overlap
Others in their field
Top investigators on “Uveitis”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Janet T. Holbrook · Johns Hopkins University$46,477,725
- Raymond Kraker · Jaeb Center For Health Research, Inc.$27,627,512
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- James T Rosenbaum · Oregon Health And Science University$15,828,860
- Nisha Acharya · University Of California, San Francisco$11,276,781
Research focus
UveitisHuman TissueClinical ResearchHuman SubjectMonoclonal AntibodyCytokine ReceptorsAntireceptor AntibodyInterleukin 2Pharmaceutical PreparationsHuman Therapy EvaluationClinical TrialsEye Disorder ChemotherapyGene ExpressionImmunosuppressiveImmunotherapyInflammatoryImmunogeneticsCytokineInflammationReportingDrug Screening /EvaluationBlindnessImmunosuppressive AgentsAutoimmune Disorder
Grant awards (51)
Humanized Anti-tac and Raptiva therapy In The Treatment Of Uveitis$396,762
Z01 · FY2008 · EY · contact PI
Treatment of choroidal subretinal neovascularization with immune agents$396,762
Z01 · FY2008 · EY · contact PI
Diagnosis And Treatment Of Ocular Inflammatory Disease (uveitis)$375,507
Z01 · FY2008 · EY · contact PI
Multicenter uveitis trial using a steroid implant and inflammatory mediators$255,061
Z01 · FY2008 · EY · contact PI
Primary Intraocular Lymphoma and Animal Models$155,871
Z01 · FY2008 · EY · contact PI
Use Of Microarrays and Epigenetics In Gene Expression Of Uveitis & AMD Patients$148,786
Z01 · FY2008 · EY · contact PI
Diagnosis And Treatment Of Ocular Inflammatory Disease (uveitis)$610,095
Z01 · FY2007 · EY · contact PI
Treatment of choroidal subretinal neovascularization with immune agents$488,942
Z01 · FY2007 · EY · contact PI
Humanized Anti-tac In The Treatment Of Uveitis$441,345
Z01 · FY2007 · EY · contact PI
Multicenter uveitis trial using a steroid implant and inflammatory mediators$186,057
Z01 · FY2007 · EY · contact PI
Use Of Cdna Microarrays In Gene Expression Of Uveitis Patients$51,923
Z01 · FY2007 · EY · contact PI
Primary Intraocular Lymphoma and Animal Models$25,961
Z01 · FY2007 · EY · contact PI
Humanized Anti-tac In The Treatment Of Uveitis$0
Z01 · FY2006 · EY · contact PI
Multicenter uveitis trial using a steroid implant and in$0
Z01 · FY2006 · EY · contact PI
Treatment of choroidal subretinal neovascularization wit$0
Z01 · FY2006 · EY · contact PI
Use Of Cdna Microarrays In Gene Expression Of Uveitis Pa$0
Z01 · FY2006 · EY · contact PI
Primary Intraocular Lymphoma and Animal Models$0
Z01 · FY2006 · EY · contact PI
Diagnosis And Treatment Of Ocular Inflammatory Disease ($0
Z01 · FY2006 · EY · contact PI
Diagnosis And Therapy Of Ocular Inflammation--Uveitis$0
Z01 · FY2005 · EY
CDNA Microarrays In Gene Expression Of Uveitis Patients$0
Z01 · FY2005 · EY
Primary Intraocular Lymphoma and Animal Models$0
Z01 · FY2005 · EY
Humanized Anti-tac In The Treatment Of Uveitis$0
Z01 · FY2005 · EY
Vegf (in Situ Macular Edema &Uveitis$0
Z01 · FY2004 · EY
Humanized Anti-tac in the Treatment of Uveitis$0
Z01 · FY2004 · EY
Diagnosis and Treatment of Ocular Inflammatory Disease$0
Z01 · FY2004 · EY
Single Nucleotide Polymorphisms In Intraocular Lymphoma$0
Z01 · FY2004 · EY
cDNA Microarrays In Gene Expression Of Uveitis Patients$0
Z01 · FY2004 · EY
Humanized Anti-tac In The Treatment Of Uveitis$0
Z01 · FY2003 · EY
Tcr Vbeta Repertoire Of T Lymphocytes-patient affect- Bi$0
Z01 · FY2003 · EY
Biology &Immunolgy Of Limbal Stem Cells And Transplanta$0
Z01 · FY2003 · EY
Use Of Cdna Microarrays In Gene Expression Of Uveitis Pa$0
Z01 · FY2003 · EY
Single Nucleotide Polymorphisms In Primary Intraocular L$0
Z01 · FY2003 · EY
The Use Of Anti-IL-2 Receptor Antibody In Behcet's Dis$0
Z01 · FY2003 · EY
VEGF in in Situ Macular Edema &Uveitis$0
Z01 · FY2003 · EY
Vegf (in Situ Macular Edema &Uveitis$0
Z01 · FY2002 · EY
Tcr Vbeta Repertoire Of T Lymphocytes-patient affect- Bi$0
Z01 · FY2002 · EY
Biolgy And Immunolgy Of Corneal Epithelial (limbal) Stem$0
Z01 · FY2002 · EY
Use Of Cdna Microarrays In Gene Expression Of Uveitis Pa$0
Z01 · FY2002 · EY
Single Nucleotide Polymorphisms In Primary Intraocular L$0
Z01 · FY2002 · EY
e Use Of An Anti-il2 Receptor Antibody In The Treatment$0
Z01 · FY2002 · EY
Humanized Anti-tac In The Treatment Of Uveitis$0
Z01 · FY2002 · EY
Humanized Anti-tac In The Treatment Of Uveitis$0
Z01 · FY2001 · EY
Tcr Vbeta Repertoire Of T Lymphocytes$0
Z01 · FY2001 · EY
Biology/Immunology Of Corneal Epithelial Stem Cells$0
Z01 · FY2001 · EY
Cdna Microarrays In Gene Expression Of Uveitis Patients$0
Z01 · FY2001 · EY
Nucleotide Polymorphisms In Primary Intraocular Lymphoma$0
Z01 · FY2001 · EY
The Use Of An Anti-il2 Receptor Antibody In The Treatmen$0
Z01 · FY2001 · EY
Vegf (in Situ Macular Edema &Uveitis$0
Z01 · FY2001 · EY
Behcet$0
Z01 · FY2000 · EY
Humanized Anti-Tac in the treatment of uveitis$0
Z01 · FY2000 · EY
VEGF (in situ macular edema &uveitis$0
Z01 · FY2000 · EY